| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/14/1994 | WO1994008010A1 Method of controlling plant pathogenic fungi |
| 04/14/1994 | WO1994008009A1 Antifungal chitin binding proteins and dna coding therefor |
| 04/14/1994 | WO1994008007A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 04/14/1994 | WO1994008006A1 Human calcitonin receptor |
| 04/14/1994 | WO1994008005A1 Novel dna, polypeptide coded for thereby, and method of detecting both |
| 04/14/1994 | WO1994008003A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE |
| 04/14/1994 | WO1994008002A2 Methods and compositions for controlling translation of hcv proteins |
| 04/14/1994 | WO1994008000A1 Pseudorabies virus vaccine |
| 04/14/1994 | WO1994007994A1 Insulin-dependent yeast or fungi |
| 04/14/1994 | WO1994007992A1 Peptides specifically binding to plasminogen and the dna encoding such peptides |
| 04/14/1994 | WO1994007920A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
| 04/14/1994 | WO1994007919A1 Insulin receptor-like protein |
| 04/14/1994 | WO1994007918A1 Multimeric polyvalent antithrombotic agents |
| 04/14/1994 | WO1994007917A1 A NOVEL β1->6 N-ACETYLGLUCOSAMINYLTRANSFERASE, ITS ACCEPTOR MOLECULE, LEUKOSIALIN, AND A METHOD FOR CLONING PROTEINS HAVING ENZYMATIC ACTIVITY |
| 04/14/1994 | WO1994007916A1 Human steroid hormone receptor neri |
| 04/14/1994 | WO1994007915A1 New growth hormone releasing hormone receptor protein |
| 04/14/1994 | WO1994007914A1 Allosteric modulators of the nmda receptor |
| 04/14/1994 | WO1994007912A1 Affinity purification methods involving amino acid mimetics as elution reagents |
| 04/14/1994 | WO1994007906A1 Epidermal surface antigen and uses thereof |
| 04/14/1994 | WO1994007902A1 Method for increasing expression and reducing expression variability of foreign genes in plant cells |
| 04/14/1994 | WO1994007533A1 Sequences of the hemagglutinins of recent strains of influenza type b virus |
| 04/14/1994 | WO1994007530A1 Vaccines and antigenic conjugates |
| 04/14/1994 | WO1994007528A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex |
| 04/14/1994 | WO1994007526A1 Insulin-like peptide |
| 04/14/1994 | WO1994007523A1 Antimicrobial peptides |
| 04/14/1994 | WO1994007522A1 Therapeutic and diagnostic methods and compositions based on transducin-like enhancer of split proteins and nucleic acids |
| 04/14/1994 | WO1994007521A1 Methods and compositions for treatment of allergic disease |
| 04/14/1994 | WO1994007520A1 Method of treating rheumatoid arthritis with type ii collagen |
| 04/14/1994 | WO1994007519A1 Growth hormone releasing peptides |
| 04/14/1994 | WO1994007518A1 Anaphylatoxin receptor ligands containing lipophilic residues |
| 04/14/1994 | WO1994007517A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/14/1994 | WO1994007516A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | WO1994007515A1 Mutant tissue factor lacking factor vii activation activity |
| 04/14/1994 | WO1994007514A1 Pulmonary delivery of active fragments of parathyroid hormone |
| 04/14/1994 | WO1994007511A1 Antibodies detecting stromelysin cleavage products |
| 04/14/1994 | WO1994007510A1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer |
| 04/14/1994 | WO1994007502A1 Characterization of a chromosome 11q23 translocation breakpoint associated with acute leukemias |
| 04/14/1994 | WO1994007474A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/14/1994 | WO1994007366A1 Pp14-based therapy |
| 04/14/1994 | WO1994007356A1 Transgenic pomaceous fruit with fire blight resistance |
| 04/14/1994 | WO1993025576A3 Peptides having platelet-derived growth factor (pdgf) activity |
| 04/14/1994 | DE4233782A1 Human embryonal kinase 2-receptor protein - useful in tumour diagnosis and therapy |
| 04/14/1994 | CA2146544A1 Ptp 1d: a novel protein tyrosine phosphatase |
| 04/14/1994 | CA2146432A1 Insulin-dependent yeast or fungi |
| 04/14/1994 | CA2146431A1 Insulin-like peptide |
| 04/14/1994 | CA2146430A1 Insulin receptor-like protein |
| 04/14/1994 | CA2146162A1 Affinity purification methods involving amino acid mimetics as elution reagents |
| 04/14/1994 | CA2145984A1 Antifungal chitin binding proteins and dna coding therefor |
| 04/14/1994 | CA2145847A1 Multimeric polyvalent antithrombotic agents |
| 04/14/1994 | CA2145769A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 04/14/1994 | CA2145762A1 Pp14-based therapy |
| 04/14/1994 | CA2145657A1 A .beta.1-6 n-acetylglucosaminyltransferase and encoding dna |
| 04/14/1994 | CA2145653A1 Transgenic pomaceous fruit with fire blight resistance |
| 04/14/1994 | CA2145517A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia - tissue factor complex |
| 04/14/1994 | CA2145418A1 Pulmonary delivery of active fragments of parathyroid hormone |
| 04/14/1994 | CA2145391A1 Vaccines and antigenic conjugates |
| 04/14/1994 | CA2144850A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
| 04/14/1994 | CA2144843A1 Antibodies detecting stromelysin cleavage products |
| 04/14/1994 | CA2142724A1 Characterization of a chromosome 11q23 translocation breakpoint associated with acute leukemias |
| 04/14/1994 | CA2124595A1 Process for detecting p53-specific antibodies |
| 04/14/1994 | CA2124566A1 Allosteric modulators of the nmda receptor |
| 04/14/1994 | CA2124330A1 Novel hirudine variant, process for producing the same, and anticoagulant containing the same as active ingredient |
| 04/13/1994 | EP0592367A2 Phosphono/biaryl substituted dipeptide derivatives |
| 04/13/1994 | EP0592358A2 Process for the production of protease inhibitors |
| 04/13/1994 | EP0592242A1 Fibrin sealant compositions and method for utilizing same |
| 04/13/1994 | EP0592230A1 Human monoclonal anti-peptide anti-body and DNA encoding thereof |
| 04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
| 04/13/1994 | EP0591914A2 Retrovirus of the HIV-group and its application |
| 04/13/1994 | EP0591789A2 Protein forming a water channel and gene therefor |
| 04/13/1994 | EP0591697A2 Cloning and characterization of the growth hormone releasing hormone receptor |
| 04/13/1994 | EP0591605A2 Method for suppressing coloring of human serum albumin |
| 04/13/1994 | EP0591530A1 Process for reducing seed storage proteins and process for transforming plants |
| 04/13/1994 | EP0591524A1 Process for producing peptide or protein |
| 04/13/1994 | EP0591483A1 Albumin-iodine preservation of blood, tissues and biological fluids |
| 04/13/1994 | EP0591462A1 Universal donor cells |
| 04/13/1994 | EP0591431A1 Hepatitis c virus (hcv) polypeptides |
| 04/13/1994 | EP0591420A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 04/13/1994 | EP0591384A1 Attenuated revertant serotype 1 marek's disease vaccine |
| 04/13/1994 | EP0591376A1 Adn sequences of the human papillomavirus type 42, and diagnostic application thereof |
| 04/13/1994 | EP0591369A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 04/13/1994 | EP0591320A1 Suppressor t-cell hybridoma |
| 04/13/1994 | EP0591316A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| 04/13/1994 | EP0591281A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them |
| 04/13/1994 | EP0591263A1 Method for inhibiting adhesion of white blood cells to endothelial cells |
| 04/13/1994 | EP0549721B1 Multiple promoter baculovirus expression system and defective particle production |
| 04/13/1994 | EP0538300B1 O-glycosylated ifn-alpha |
| 04/13/1994 | EP0475971B1 A hemoglobin composition and its use |
| 04/13/1994 | EP0420936B1 Purified ubiquitin hydrolase, dna sequences encoding same, and its use in recovering polypeptides |
| 04/13/1994 | EP0406395B1 Process for testing for pathogenic listeria bacteria |
| 04/13/1994 | EP0396616B1 Reduction of side effects of cancer therapy |
| 04/13/1994 | EP0264434B1 Detection of a unique chlamydia strain associated with acute respiratory disease |
| 04/13/1994 | CN1085254A Recombinant DNA encoding a desulfurization biocatalyst |
| 04/13/1994 | CN1085253A Dictyostelium dipeptidylaminopeptidase |
| 04/12/1994 | US5302715 For binding to antigens, proteins, polypeptides or other labels for preparation of antibodies useful in immunoassays |
| 04/12/1994 | US5302706 Senescent cell derived inhibitors of DNA synthesis |
| 04/12/1994 | US5302703 For making antibodies or receptors to metabolism products of tetrahydrocannabinol for use in immunoassays |
| 04/12/1994 | US5302702 Chimeric fibroblast growth factors |
| 04/12/1994 | US5302701 Cell growth promoting activity |
| 04/12/1994 | US5302699 Antitumorigenic protein, method of preparing it and antitumorigenic composition containing the protein as active component |
| 04/12/1994 | US5302698 Promotes transcription of fetoprotein gene |